Koninklijke Philips PHG
NYSE PHG
$27.67 +0.05 (+0.18%)
At close: Aug 20, 2026 · 10:26 AM UTC

Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026)

Koninklijke Philips (PHG) posted quarterly Net Income towards Common Stockholders of $446.3 million for Q2 2026, up 64.3% year-over-year from $271.7 million in Q2 2025, and up 152.48% quarter-over-quarter from $176.8 million in Q1 2026.

Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Koninklijke Philips' Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $446.3 million for Q2 2026.

  • In Q2 2026, Net Income towards Common Stockholders rose 64.3% year-over-year to $446.3 million; the TTM figure through Jun 2026 stood at $1.7 billion (up 761.82% YoY), while the FY2025 annual figure was $1.0 billion, up 238.88% from the prior year.
  • Net Income towards Common Stockholders for Q2 2026 stood at $446.3 million, up from $176.8 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $584.5 million in Q3 2025, with the low at -$356.9 million in Q4 2024.
  • The 5-year median for Net Income towards Common Stockholders is -$73879.9 (2022), against an average of $130.0 million.
  • Peak annual rise in Net Income towards Common Stockholders reached 69789.8% in 2024, while the deepest fall reached 829400.18% in 2024.
  • Koninklijke Philips' Net Income towards Common Stockholders stood at -$1.8 million in 2022, then jumped by 102.4% to $43037.6 in 2023, then plunged by 829400.18% to -$356.9 million in 2024, then jumped by 228.83% to $459.8 million in 2025, then decreased by 2.93% to $446.3 million in 2026.
  • Business Quant data shows PHG's Net Income towards Common Stockholders at $446.3 million in Q2 2026, $176.8 million in Q1 2026, and $459.8 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.70 Bn 194.09 Bn 7.27 Bn 928.00 Mn
2 Stryker 129.82 Bn 126.34 Bn 4.50 Bn 1.28 Bn
3 Medtronic 120.34 Bn 111.12 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 74.41 Bn 73.88 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 52.56 Bn 48.31 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.76 Bn 32.82 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.84 Bn 31.73 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.44 Bn 23.12 Bn 4.55 Bn 621.86 Mn
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 201.00 Mn
10 Zimmer Biomet Holdings 19.42 Bn 19.01 Bn 1.54 Bn 199.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 446.35 Mn
Mar 31, 2026 176.78 Mn
Dec 31, 2025 459.80 Mn
Sep 30, 2025 584.53 Mn
Jun 30, 2025 271.67 Mn
Mar 31, 2025 79.94 Mn
Dec 31, 2024 -356.91 Mn
Sep 30, 2024 198.78 Mn
Jun 30, 2024 485.68 Mn
Mar 31, 2024 -1.19 Mn
Dec 31, 2023 43,037.60
Sep 30, 2023 -587,838.86
Jun 30, 2023 -696,911.61
Mar 31, 2023 -772,806.11
Dec 31, 2022 -1.80 Mn
Sep 30, 2022 -1.65 Mn
Jun 30, 2022 -202,740.77
Mar 31, 2022 -190,797.41
Dec 31, 2021 766,460.54
Sep 30, 2021 601,436.53